Anixa Biosciences's total assets for Q3 2026 were $15.07M, an increase of 1.41% from the previous quarter. DE:CY71 total liabilities were $1.87M for the fiscal quarter, a 14.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.